blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3927811

EP3927811 - BIOFUNCTIONALIZED HYDROGEL FOR CELL CULTURE [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  26.11.2021
Database last updated on 03.06.2024
FormerThe international publication has been made
Status updated on  28.08.2020
Most recent event   Tooltip27.02.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Vanderbilt University
305 Kirkland Hall
2201 West End Avenue
Nashville, TN 37240 / US
[2021/52]
Inventor(s)01 / LIPPMANN, Ethan, S.
C/o Vanderbilt University 305 Kirland Hall 2201
West End Avenue
Nashville, TN 37240 / US
02 / BALOTIN, Kylie
C/o Vanderbilt University 305 Kirkland Hall 2201
West End Avenue
Nashville, TN 37240 / US
03 / O'GRADY, Brian
C/o Vanderbilt University 305 Kirkland Hall 2201
West End Avenue
Nashville, TN 37240 / US
04 / BELLAN, Leon, M.
C/o Vanderbilt University 305 Kirkland Hall 2201
West End Avenue
Nashville, TN 37240 / US
[N/P]
Former [2021/52]01 / LIPPMANN, Ethan, S.
Nashville, TN 37240 / US
02 / BALOTIN, Kylie
Nashville, TN 37240 / US
03 / O'GRADY, Brian
Nashville, TN 37240 / US
04 / BELLAN, Leon, M.
Nashville, TN 37240 / US
Representative(s)Marks & Clerk LLP
15 Fetter Lane
London EC4A 1BW / GB
[N/P]
Former [2021/52]Stafford, Jonathan Alan Lewis
Marks & Clerk LLP
1 New York Street
Manchester M1 4HD / GB
Application number, filing date20759186.821.02.2020
[2021/52]
WO2020US19369
Priority number, dateUS201962809184P22.02.2019         Original published format: US 201962809184 P
US201962828806P03.04.2019         Original published format: US 201962828806 P
US201962857575P05.06.2019         Original published format: US 201962857575 P
[2021/52]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020172637
Date:27.08.2020
Language:EN
[2020/35]
Type: A1 Application with search report 
No.:EP3927811
Date:29.12.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 27.08.2020 takes the place of the publication of the European patent application.
[2021/52]
Search report(s)International search report - published on:US27.08.2020
(Supplementary) European search report - dispatched on:EP20.10.2022
ClassificationIPC:C12N5/00, C07K7/04, C07K14/00, C07K17/08, C07K14/78
[2022/47]
CPC:
C07K17/08 (EP); C12N5/0697 (US); C07K14/78 (EP);
C08H1/06 (US); C08J3/075 (US); C08J3/24 (US);
C08L89/06 (US); C12N5/0068 (EP); C12N5/0619 (US);
C12N5/0622 (US); C12N5/0691 (US); C08J2389/06 (US);
C08L2312/00 (US); C12N2500/32 (EP); C12N2502/081 (US);
C12N2502/086 (US); C12N2506/45 (US); C12N2513/00 (US);
C12N2533/54 (EP,US); C12N2537/10 (EP,US) (-)
Former IPC [2021/52]C12N5/00, C07K7/04, C07K14/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/52]
TitleGerman:BIOFUNKTIONALISIERTES HYDROGEL FÜR ZELLKULTUR[2021/52]
English:BIOFUNCTIONALIZED HYDROGEL FOR CELL CULTURE[2021/52]
French:HYDROGEL BIOFONCTIONNALISÉ POUR CULTURE CELLULAIRE[2021/52]
Entry into regional phase12.08.2021National basic fee paid 
12.08.2021Search fee paid 
12.08.2021Designation fee(s) paid 
12.08.2021Examination fee paid 
Examination procedure12.08.2021Examination requested  [2021/52]
18.05.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
25.02.2022Renewal fee patent year 03
27.02.2023Renewal fee patent year 04
27.02.2024Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]US2018171286  (BANERJEE IPSITA [US], et al) [X] 1-7,10-12,14,15 * General cross-linking in hydrogels; paragraphs [0035] - [0038] * * N-Cadhedrin comprising HAV motif, conjugated to alginate hydrogel, X-linked. Propagation of pluripotent stem cells from single cells in hydrogel.; paragraph [0044] - paragraph [0051]; figures 2-3, 8 * * Reference to differentiation of hMSC into chondrocyte tissue.; paragraph [0105] *;
 [X]  - ZHU MEILING ET AL, "Hydrogels functionalized with N-cadherin mimetic peptide enhance osteogenesis of hMSCs by emulating the osteogenic niche", BIOMATERIALS, ELSEVIER, AMSTERDAM, NL, (20151102), vol. 77, doi:10.1016/J.BIOMATERIALS.2015.10.072, ISSN 0142-9612, pages 44 - 52, XP029338009 [X] 1-8,10,11,14,15 * abstract * * Osteogenesis of MSC promoted in N-Cadhedrin derived polypetide conjugated to HA crosslinked hydrogel.; page 44, column 2, paragraph 2 - page 45, column 1, paragraph 1; figure 4 * * Materials and Methods 4.1 Macromer sysnthesis and hydrogel preparation 4.2 Cell culture and seeding on hydrogels; page 50, paragraph 4.1 - paragraph 4.2 *

DOI:   http://dx.doi.org/10.1016/j.biomaterials.2015.10.072
 [X]  - SCHENSE J C ET AL, "ENZYMATIC INCORPORATION OF BIOACTIVE PEPTIDES INTO FIBRIN MATRICES ENHANCES NEURITE EXTENSION", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP US, NEW YORK, (20000401), vol. 18, doi:10.1038/74473, ISSN 1087-0156, pages 415 - 419, XP001134964 [X] 1-3,6,7,10-12,14,15 * abstract * * Experimental Protocol Enzymatic crosslinking of HAV motif petides and others in combination using Factor VIII in fibrinogen / thrombin matrix. Outgrowth of neurite from chick embryo dorsal root ganglia; page 418, column 2, paragraph 3 - page 419, column 1, paragraph 1 *

DOI:   http://dx.doi.org/10.1038/74473
International search[X]US2018171286  (BANERJEE IPSITA [US], et al) [X] 1, 3/1, 29 * claims 1-8 *;
 [X]  - ZHU et al., "Hydrogels functionalized with N-cadherin mimetic peptide enhance osteogenesis of hMSCs by emulating the osteogenic niche", Biomaterials, (20160100), vol. 77, doi:10.1016/j.biomaterials.2015.10.072, pages 44 - 52, XP029338009 [X] 1-3, 29 * ; Abstract, pg 50, col 2 *

DOI:   http://dx.doi.org/10.1016/j.biomaterials.2015.10.072
 [X]  - AN et al., "Hyaluronate-alginate hybrid hydrogels modified with biomimetic peptides for controlling the chondrocyte phenotype", Carbohydr Polym., (20181001), vol. 197, doi:10.1016/j.carbpol.2018.06.016, pages 422 - 430, XP085428072 [X] 1, 3/1, 29 * ; Abstract, pg 423, col 2; pg 425, Fig. 2 and its legend *

DOI:   http://dx.doi.org/10.1016/j.carbpol.2018.06.016
 [X]  - BIAN et al., "Hydrogels that mimic developmentally relevant matrix and N-cadherin interactions enhance MSC chondrogenesis", Proc Natl Acad Sci USA, (20130618), vol. 110, no. 25, pages 10117 - 10122, XP055734783 [X] 1-3, 29 * ; Abstract, pg 10121 col 1 *

DOI:   http://dx.doi.org/10.1073/pnas.1214100110
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.